Research

Thumbnail image for LSD Enhances Emotional Responses to Music

LSD Enhances Emotional Responses to Music

August 11, 2015 LSD

The latest scientific paper to come out of the Beckley/Imperial Psychedelic Research Programme has been published today online in Psychopharmacology, and will be published in print later this month. The paper, titled LSD enhances the emotional response to music investigates how LSD affects people’s emotional responses to music. Music is considered an important element in […]

Continue Reading →
Thumbnail image for The Beckley Foundation at Breaking Convention 2015

The Beckley Foundation at Breaking Convention 2015

July 13, 2015 LSD

Last weekend, between the 10th and 12th July 2015, the University of Greenwich hosted Breaking Convention 2015, one of the biggest conferences in the world specialising on psychedelics and consciousness. Over 800 experts, artists, academics, and members of the civil society and the general public took part in dozens of panels, talks, concerts, film screenings […]

Continue Reading →
Thumbnail image for “What the results of the cannabis trial show is that Prohibition must end”

“What the results of the cannabis trial show is that Prohibition must end”

March 5, 2015 Policy

The social life of the cannabis plant dates back to more than ten millenia. Many studies have been written on this subject, but they tend to focus on the problematic aspects of use, which are suffered by a small percentage of the total number of users. The policies of prohibition have reinforced this negative bias, […]

Continue Reading →
Thumbnail image for Beckley Foundation’s Research on Cannabis

Beckley Foundation’s Research on Cannabis

March 3, 2015 Cannabis

Cannabis is among the most studied psychoactive substances in the world. However, the hundreds of thousands of journal articles on this substance tend to focus on the ‘problematic’ aspects of the drug’s social life from the perspectives of psychiatry, epidemiology, criminology, etc. The policies of prohibition have played a central role in instigating this bias. […]

Continue Reading →

Frequently Asked Questions Beckley-Imperial College Research Programme

September 26, 2014 LSD

  BECKLEY FOUNDATION–IMPERIAL COLLEGE RESEARCH PROGRAMME Psychedelics   What is the background to the psychedelic research being carried out at Imperial? It is part of the Beckley Foundation–Imperial College Psychopharmacological Research Programme, which was set up in 2009 by Amanda Feilding (Director of the Beckley Foundation) and Professor David Nutt (Head of Neuropsychopharmacology at Imperial […]

Continue Reading →
Thumbnail image for How Ecstasy Acts on The Brain And Hints at Therapeutic Uses

How Ecstasy Acts on The Brain And Hints at Therapeutic Uses

January 24, 2014 BF Scientific Publications

MDMA is by no means a new substance in the drug landscape. Its recreational use sparked in the 1980s and has been sustained until now. However, veiled by a mix of urban legend, unscrupulous reporting and particularly harsh regulation; its mechanisms of action have remained mostly unknown. One of our goals here at the Beckley […]

Continue Reading →
Thumbnail image for A discussion on scientific research with psychedelic drugs

A discussion on scientific research with psychedelic drugs

June 12, 2013 Psilocybin Featured

A series of discussions, organised by the Beckley Foundation’s collaboration with Imperial College London’s Neuropsychopharmacology unit, will be held on Wednesday 12th June at the university. Researches from around the world will be in attendance, presenting their latest findings and discussing new ideas arising as a result.

Continue Reading →
Thumbnail image for Amanda Feilding’s introductory address at Psychedelic Science 2013

Amanda Feilding’s introductory address at Psychedelic Science 2013

May 4, 2013 Beckley in the Media

Read Amanda Feilding’s introductory address at the Psychedelic Science Conference 2013, held in Oakland California on 18-22 April. The conference was co-hosted by the Beckley Foundation, Multidisciplinary Association for Psychedelic Studies (MAPS), Heffter, and the Council for Spiritual Practices.

Continue Reading →
Thumbnail image for Amanda Feilding’s speaks at Psychedelic Science 2013

Amanda Feilding’s speaks at Psychedelic Science 2013

May 1, 2013 Beckley in the Media

Read Amanda Feilding’s talk at the Psychedelic Science Conference 2013, held in Oakland California on 18-22 April. The conference was co-hosted by the Beckley Foundation, Multidisciplinary Association for Psychedelic Studies (MAPS), Heffter, and the Council for Spiritual Practices.

Continue Reading →
Thumbnail image for Psychedelic Science Conference 2013

Psychedelic Science Conference 2013

April 26, 2013 Beckley in the Media

The Psychedelic Science conference, co-hosted by the Beckley Foundation, brought together researchers from around the world to discuss research, clinical trials, and medical discoveries involving psychedelic substances. Amanda Feilding presented the results of the Beckley Foundation research programme, including our recent investigations into psilocybin and MDMA.

Continue Reading →
Thumbnail image for Amanda Feilding Interviewed in the Evening Standard

Amanda Feilding Interviewed in the Evening Standard

April 16, 2013 Beckley in the Media

Amanda talks about her life, psilocybin research and all Beckley Foundation projects in this interview with the Evening Standard.

Continue Reading →
Thumbnail image for Government Restrictions Obstruct Crucial Mental Health Research

Government Restrictions Obstruct Crucial Mental Health Research

April 15, 2013 Beckley in the Media

Current drug policies stifle important scientific and clinical research by placing an intolerable burden of regulation on scientists who wish to work with ‘controlled substances’, meaning that very few even try to do so.

Continue Reading →
Amanda Feilding - Interviewed for the New Scientist

The Queen of Consciousness – Amanda Feilding interviewed for the New Scientist

December 20, 2012 Beckley in the Media

Amanda Feilding is featured in this week’s Opinion Interview in New Scientist. In it, she talks about the origins of the Beckley Foundation and its groundbreaking work in the field of scientific research and drug policy reform. You can read the full interview here.

Continue Reading →

Comment: Politicians don’t have the guts to support us in public

December 6, 2012 Beckley in the Media

Politicians will say many things privately but never dare utter them in public, especially when in office. Only when they are out of power do they reveal their true feelings. And this is no truer than the when addressing the ‘D’ word – drugs. Support the regulation of drugs and your career could be over. Or could it?

Continue Reading →

The Beckley Foundation Scientific Programme

October 31, 2012 Research

The Beckley Foundation Scientific Programme works at the frontiers of research into psychoactive substances, their effects on the brain and consciousness, and their potential therapeutic benefits.

Continue Reading →

A Fresh Approach to Drugs – the UK Drug Policy Commission Report

October 15, 2012 Cannabis

The Beckley Foundation welcomes the report of the UK Drug Policy Commission published this week, a culmination of 6 years of in-depth analysis into all aspects of UK drug policy. The Commission, comprised of a distinguished multi-disciplinary panel of experts, has reached many of the same conclusions as those emerging from the work of the Beckley […]

Continue Reading →

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

October 15, 2012 BF Scientific Publications

A new analysis of the original psilocybin fMRI data has recently been published in a new paper in Schizophrenia Bulletin, in which the psychedelic state is analysed for similarity with early psychosis, as both share similar effects on how different areas of the brain communicate with eachother.

Continue Reading →

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

October 11, 2012 BF Scientific Publications

Amanda Feilding is one of 14 authors on a new study which supports the idea that high-THC/low-CBD cannabis products are associated with increased risks for mental health. Click the link to download the full PDF from the Journal of Psychopharmacology Click here to download the original article and access the FULL PDF document In this […]

Continue Reading →
http://www.beckleyfoundation.org/wp-content/uploads/2013/05/mdma-pills.png

MDMA may help treat depression and PTSD, Channel 4 study suggests

September 28, 2012 Beckley in the Media

Research hints at therapeutic uses for MDMA – but the taboo surrounding psychoactive drugs prevents similar studies by Amanda Feilding Click here for original Article in The Guardian I was amused by Conal Urquhart’s description in the Observer of the novelist Lionel Shriver being sucked into an MRI brain scanner “that resembles a giant washing machine”. I see […]

Continue Reading →

Friction and addiction: the use of illicit drugs in Australian research

August 6, 2012 Worldwide Psychedelic Research

Criminalisation of many drugs of abuse has done little to deter their use. Recent estimates tell us nearly one in 20 individuals aged between 15 and 64 are experimenting with illicit drug use worldwide. But contrary to the recent statements by Professor David Nutt in the UK, legislation regarding the use of illicit drugs for research purposes has had […]

Continue Reading →

L.A. City Council votes 14-0 to ban medical marijuana shops

July 25, 2012 Cannabis

In the latest attempt to regulate what many say is an out-of-control proliferation of medical marijuana dispensaries in Los Angeles, the City Counted voted 14-0 Tuesday to ban pot shops. Under the ban, each of the 762 dispensaries that have registered with the city will be sent a letter ordering them to shut down immediately. […]

Continue Reading →

Channel 4 to screen volunteers taking the drug Ecstasy

July 20, 2012 Beckley Science in the Media

An experiment in which volunteers take the dance drug Ecstasy is to be screened on Channel 4 in a first for British television. This research forms part of the Beckley Foundation/Imperial College Psychedelic Research Programme: a collaboration between Amanda Fielding and Prof. David Nutt’s team at Imperial College. July 2012 Click here for original article […]

Continue Reading →
Thumbnail image for Scientists’ agony over ecstasy

Scientists’ agony over ecstasy

July 19, 2012 MDMA

Until science can freely study drugs like MDMA, their great therapeutic potential will stay untapped David Nutt There are some goals most scientists share when they embark on their career: to advance your field, to make discoveries, to innovate and to increase knowledge. All of which help towards the scientist’s ultimate aim: to improve quality […]

Continue Reading →

Study: The ‘gateway drug’ is alcohol, not marijuana

July 10, 2012 Cannabis

By Stephen C. Webster Thursday, July 5, 2012 A study in the August edition of The Journal of School Health finds that the generations old theory of a “gateway drug” effect is in fact accurate for some drug users, but shifts the blame for those addicts’ escalating substance abuse away from marijuana and onto the most […]

Continue Reading →

MDMA Turns 100 Years Old, Still Faces Stereotypes. Part 2

June 29, 2012 MDMA

Click here for original article Care2: How is MDMA being used to treat those suffering from PTSD? Burge: “It’s not the MDMA alone, but how it is used in combination with psychotherapy, that can help people suffering from PTSD. MDMA can actually increase the effectiveness of psychotherapy, allowing people with PTSD to discuss their painful memories […]

Continue Reading →

MDMA Turns 100 Years Old, Still Faces Stereotypes

June 29, 2012 MDMA

JUNE 2012 Beth Buczynski On an unknown date in 1912, Dr. Anton Köllisch of the Merck Pharmaceutical Company was working on creating a new blood-clotting medication. During his research, he discovered a string of new chemicals, one of which was named 3,4-methylenedioxy-N-methylamphetamine, or MDMA. At the time, neither Dr. Köllisch or Merck were aware of the drug’s psychoactive effects, […]

Continue Reading →

Are We Finally Reawakening to the Profound Healing Properties of Psychedelics?

June 18, 2012 MDMA

Legal research on a range of currently illegal drugs indicates they may help cure PTSD, alcoholism and even cluster headaches June 14, 2012  | Slowly but surely, we may be reaching success in a determined and long-time legal effort to unleash the curative powers of psychedelic drugs in America. There is a tremendous need for […]

Continue Reading →

Study: Cannabis Use Associated With Lower Mortality Risk In Patients With Psychotic Disorders

June 14, 2012 Cannabis

by Paul Armentano, NORML Deputy Director May 29, 2012 The use of cannabis is associated with lower mortality risk in patients with schizophrenia and related psychotic disorders, according to a forthcoming study to be published in the Journal of Psychiatric Research. (Read the abstract of the study online here.) The use of cannabis is associated […]

Continue Reading →

Pure ecstasy can be ‘safe’ if consumed responsibly: B.C. health officer

June 14, 2012 Global Policy News

Tamsyn Burgmann, Thursday, June 14, 2012 4:35 AM Read it on Global News: Global News | Pure ecstasy can be ‘safe’ if consumed responsibly: B.C. health officer   VANCOUVER – B.C.’s top health official says taking pure ecstasy can be “safe” when consumed responsibly by adults, despite warnings by police in Alberta and British Columbia […]

Continue Reading →

Is the future of drugs safe and non-addictive?

June 11, 2012 Drug abuse

In years to come alcohol may be replaced with happier alternatives and we could all be immunised against developing harmful habits   The next 20 years hold great opportunities for drugs research. We could see the development of pharmacological substitutes, agents to block the effects of drugs and help people break addictions, and drug-based aids […]

Continue Reading →